Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00168155
Status:
COMPLETED
Last Update Posted:
2012-01-19
First Post:
2005-09-13
Brief Title:
Study of 5-FU Leucovorin CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
Sponsor:
Alberta Health services
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
Phase 2 Study of Neoadjuvant 5-FU Leucovorin CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
When colon or rectal cancer has spread to the liver the cancer in the liver can sometimes be removed surgically However the cancer has a chance or reoccurring in the liver or elsewhere in the body This study will determine if giving chemotherapy treatment before the surgery can reduce the chances that the cancer will come back
Detailed Description:
When colon or rectal cancer has spread to the liver the cancer in the liver can sometimes be removed surgically However the cancer has a chance or reoccurring in the liver or elsewhere in the body This study will determine if giving chemotherapy treatment before the surgery can reduce the chances that the cancer will come back
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None